Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa (Q38976930)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa |
scientific article |
Statements
1 reference
Olanzapine versus chlorpromazine in the treatment of schizophrenia: a pooled analysis of four 6-week, randomized, open-label studies in the Middle East and North Africa (English)
1 reference
Martin Dossenbach
1 reference
Tamás Treuer
1 reference
Ludmila Kryzhanovskaya
1 reference
Mete Saylan
1 reference
Svetlana Dominguez
1 reference
Xiaohong Huang
1 reference
HGCQ, HGDQ, HGDT, and HGDV Study Team
1 reference
1 August 2007
1 reference
1 reference
Identifiers
1 reference